Analyst firms · Citizens JMP · ALLO

Citizens JMP ALLO price target and rating history

Allogene Therapeutics Inc. (ALLO) · Health Care

Citizens JMP rates Allogene Therapeutics Inc. (ALLO) Mkt Outperform with a $5 price target, as of its latest action on Jan 9, 2026. It has published 5 rating actions on ALLO since October 2021, including 2 upgrades and 2 downgrades.

Current rating
Mkt Outperform
Price target
$5
Median target, all firms
Too few
Actions on ALLO
5

Citizens JMP price target on ALLO

$27$16$520222023202420252026
Citizens JMP price target on ALLO, each point a stated target, October 2021 to January 2026.

Every Citizens JMP rating on ALLO

How other firms rate ALLO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesBuy$6Apr 10, 2026
Citizens JMPMkt Outperform$5Jan 9, 2026

Questions about Citizens JMP and ALLO

What is Citizens JMP's price target for ALLO?
Citizens JMP's latest stated price target for Allogene Therapeutics Inc. (ALLO) is $5, from its action on Jan 9, 2026.
What is Citizens JMP's rating on ALLO?
Citizens JMP rates ALLO Mkt Outperform, a bullish rating, as of Jan 9, 2026.
When did Citizens JMP last change its view on ALLO?
On Jan 9, 2026, Citizens JMP upgrades to Mkt Outperform from Mkt Perform, price target $5.

More ALLO rating histories

All Citizens JMP ratingsALLO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.